Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature

被引:2
作者
Goldman, Jason D. [1 ,2 ]
Diaz, George [3 ]
Urba, Walter J. [4 ,5 ]
机构
[1] Swedish Med Ctr, Div Infect Dis, 1124 Columbia St,600, Seattle, WA 98104 USA
[2] Swedish Med Ctr, Div Organ Transplant, 1124 Columbia St,600, Seattle, WA 98104 USA
[3] Providence Reg Med Ctr, Div Infect Dis, Everett, WA USA
[4] Providence Canc Inst Franz Clin, Div Hematol, Portland, OR USA
[5] Providence Canc Inst Franz Clin, Div Med Oncol, Portland, OR USA
关键词
D O I
10.1016/j.ijantimicag.2020.106174
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页数:1
相关论文
共 5 条
[1]  
Chen Z, 2020, IN PRESS, DOI [10.1101/2020.03.22.20040758, 10.1101/2020.03.22.20040758.]
[2]  
Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI [10.1016/j.ijantimicag.2020.105949, 10.1016/j.ijantimicag.2020.106063]
[3]   SARS-CoV-2 Infection in Children [J].
Lu, Xiaoxia ;
Zhang, Liqiong ;
Du, Hui ;
Zhang, Jingjing ;
Li, Yuan Y. ;
Qu, Jingyu ;
Zhang, Wenxin ;
Wang, Youjie ;
Bao, Shuangshuang ;
Li, Ying ;
Wu, Chuansha ;
Liu, Hongxiu ;
Liu, Di ;
Shao, Jianbo ;
Peng, Xuehua ;
Yang, Yonghong ;
Liu, Zhisheng ;
Xiang, Yun ;
Zhang, Furong ;
Silva, Rona M. ;
Pinkerton, Kent E. ;
Shen, Kunling ;
Xiao, Han ;
Xu, Shunqing ;
Wong, Gary W. K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (17) :1663-1665
[4]  
Piller C, FORMER FDA LEADERS D
[5]   In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) [J].
Yao, Xueting ;
Ye, Fei ;
Zhang, Miao ;
Cui, Cheng ;
Huang, Baoying ;
Niu, Peihua ;
Liu, Xu ;
Zhao, Li ;
Dong, Erdan ;
Song, Chunli ;
Zhan, Siyan ;
Lu, Roujian ;
Li, Haiyan ;
Tan, Wenjie ;
Liu, Dongyang .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) :732-739